Low-cost Haemophilia A treatment deal unlocks world of opportunity for ProFactor Pharma

Low-cost Haemophilia A treatment deal unlocks world of opportunity for ProFactor Pharma New agreement with Bio Farma opens estimated $1.36bn addressable Asian market A new patented process to make low-cost treatment for Haemophilia A, developed by Scottish biotechnology company ProFactor Pharma Ltd (PFP),...

Related Keywords

Malaysia ,Philippines ,United States ,Thailand ,India ,United Kingdom ,Singapore ,Vietnam ,Republic Of ,Indonesia ,America ,Scotland ,Jaymin Amin ,Richard Cruse ,Profactor Pharma ,Bio Farma ,Honesti Basyir ,Bio Farma Persero ,Product Development ,Profactor Pharma Ltd ,World Federation Of Hemophilia ,Low Cost Haemophilia ,Technology Transfer ,Licence Agreement ,Southeast Asia ,Recombinant Human Factor ,Middle East ,Eastern Europe ,South America ,President Director ,Scottish Enterprise ,Factor Pharma ,